Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%

Overall survival · Patients treated with curative intent for colorectal cancer with neoadjuvant and/or adjuvant chemotherapy

Oral showed no clear difference in overall survival compared with intravenous fluoropyrimidines (high certainty).

1 finding from 1 review

Oral versus intravenous fluoropyrimidines for colorectal cancer 2017 · Cochrane Headline outcomes only
HR 0.92 [0.84, 1]
7 studies · 8902 participants
High

Overall survival · Patients treated with palliative intent for inoperable advanced or metastatic colorectal cancer with chemotherapy

Oral showed no clear difference in overall survival compared with intravenous fluoropyrimidines (high certainty).

1 finding from 1 review

Oral versus intravenous fluoropyrimidines for colorectal cancer 2017 · Cochrane Headline outcomes only
HR 1.02 [0.99, 1.05]
29 studies · 12079 participants
High